229 related articles for article (PubMed ID: 28329322)
1. Utilization and in-hospital complications of cardiac resynchronization therapy: trends in the United States from 2003 to 2013.
Hosseini SM; Moazzami K; Rozen G; Vaid J; Saleh A; Heist KE; Vangel M; Ruskin JN
Eur Heart J; 2017 Jul; 38(27):2122-2128. PubMed ID: 28329322
[TBL] [Abstract][Full Text] [Related]
2. Frequency of in-hospital adverse outcomes and cost utilization associated with cardiac resynchronization therapy defibrillator implantation in the United States.
Patel N; Viles-Gonzalez J; Agnihotri K; Arora S; Patel NJ; Aneja E; Shah M; Badheka AO; Pothineni NV; Kancharla K; Mulpuru S; Noseworthy PA; Kusumoto F; Cha YM; Deshmukh AJ
J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1425-1435. PubMed ID: 30016005
[TBL] [Abstract][Full Text] [Related]
3. National Trends in the Use of Cardiac Resynchronization Therapy With or Without Implantable Cardioverter-Defibrillator.
Lindvall C; Chatterjee NA; Chang Y; Chernack B; Jackson VA; Singh JP; Metlay JP
Circulation; 2016 Jan; 133(3):273-81. PubMed ID: 26635400
[TBL] [Abstract][Full Text] [Related]
4. Sex Disparities in the Choice of Cardiac Resynchronization Therapy Device: An Analysis of Trends, Predictors, and Outcomes.
Mohamed MO; Contractor T; Zachariah D; van Spall HGC; Parwani P; Minissian MB; Rashid M; Martin GP; Barker D; Patwala A; Mamas MA
Can J Cardiol; 2021 Jan; 37(1):86-93. PubMed ID: 32376344
[TBL] [Abstract][Full Text] [Related]
5. Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis.
Zhan C; Baine WB; Sedrakyan A; Steiner C
J Gen Intern Med; 2008 Jan; 23 Suppl 1(Suppl 1):13-9. PubMed ID: 18095038
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Resynchronization Therapy: US Trends and Disparities in Utilization and Outcomes.
Sridhar AR; Yarlagadda V; Parasa S; Reddy YM; Patel D; Lakkireddy D; Wilkoff BL; Dawn B
Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e003108. PubMed ID: 26921376
[TBL] [Abstract][Full Text] [Related]
7. Impact of haematoma after pacemaker and CRT device implantation on hospitalization costs, length of stay, and mortality: a population-based study.
Sridhar AR; Yarlagadda V; Yeruva MR; Kanmanthareddy A; Vallakati A; Dawn B; Lakkireddy D
Europace; 2015 Oct; 17(10):1548-54. PubMed ID: 25855676
[TBL] [Abstract][Full Text] [Related]
8. Incidence and outcomes of cardiac tamponade in patients undergoing cardiac resynchronization therapy.
Adegbala O; Olagoke O; Adejumo A; Akintoye E; Oluwole A; Alebna P; Williams K; Lieberman R; Afonso L
Int J Cardiol; 2018 Dec; 272():137-141. PubMed ID: 30045818
[TBL] [Abstract][Full Text] [Related]
9. Occurrence, mortality and predictors of complicated cardiac perforation in patients with CRT-D: Based on the National Inpatient Sample registry.
Kawata H; Erande A; Lafi O; Chen CW; Hirai T; Santucci P; Malik S
Int J Cardiol; 2019 Oct; 293():109-114. PubMed ID: 31147194
[TBL] [Abstract][Full Text] [Related]
10. The prognostic benefit of cardiac resynchronization therapy is greater in concordant vs. discordant left bundle branch block in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
Padeletti L; Aimo A; Vishenvsky B; Schwartz A; McNitt S; Wang PJ; Moss AJ; Emdin M; Zareba W
Europace; 2018 May; 20(5):794-800. PubMed ID: 28398490
[TBL] [Abstract][Full Text] [Related]
11. Increasing sex differences in the use of cardiac resynchronization therapy with or without implantable cardioverter-defibrillator.
Chatterjee NA; Borgquist R; Chang Y; Lewey J; Jackson VA; Singh JP; Metlay JP; Lindvall C
Eur Heart J; 2017 May; 38(19):1485-1494. PubMed ID: 28065904
[TBL] [Abstract][Full Text] [Related]
12. Trends and outcomes of cardiac resynchronization therapy upgrade procedures: A comparative analysis using a United States National Database 2003-2013.
Cheung JW; Ip JE; Markowitz SM; Liu CF; Thomas G; Feldman DN; Swaminathan RV; Lerman BB; Kim LK
Heart Rhythm; 2017 Jul; 14(7):1043-1050. PubMed ID: 28214565
[TBL] [Abstract][Full Text] [Related]
13. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
[TBL] [Abstract][Full Text] [Related]
14. Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort.
Varma N; Mittal S; Prillinger JB; Snell J; Dalal N; Piccini JP
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490521
[TBL] [Abstract][Full Text] [Related]
15. Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker.
Schuchert A; Muto C; Maounis T; Frank R; Boulogne E; Polauck A; Padeletti L;
Europace; 2013 Jan; 15(1):71-6. PubMed ID: 22927665
[TBL] [Abstract][Full Text] [Related]
16. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.
Palmisano P; Accogli M; Zaccaria M; Luzzi G; Nacci F; Anaclerio M; Favale S
Europace; 2013 Apr; 15(4):531-40. PubMed ID: 23407627
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics and Outcomes of Older Cardiac Resynchronization Therapy Recipients Using a Pacemaker versus a Defibrillator.
Munir MB; Althouse AD; Rijal S; Shah MB; Abu Daya H; Adelstein E; Saba S
J Cardiovasc Electrophysiol; 2016 Jun; 27(6):730-4. PubMed ID: 26856440
[TBL] [Abstract][Full Text] [Related]
18. Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience.
Kutyifa V; Geller L; Bogyi P; Zima E; Aktas MK; Ozcan EE; Becker D; Nagy VK; Kosztin A; Szilagyi S; Merkely B
Eur J Heart Fail; 2014 Dec; 16(12):1323-30. PubMed ID: 25379962
[TBL] [Abstract][Full Text] [Related]
19. Does Age Influence Cardiac Resynchronization Therapy Use and Outcome?
Heidenreich PA; Tsai V; Bao H; Curtis J; Goldstein M; Curtis L; Hernandez A; Peterson P; Turakhia MP; Masoudi FA
JACC Heart Fail; 2015 Jun; 3(6):497-504. PubMed ID: 25982109
[TBL] [Abstract][Full Text] [Related]
20. Impact of institutional procedural volume on inhospital outcomes after cardiac resynchronization therapy device implantation: US national database 2003-2011.
Yeo I; Kim LK; Lerman BB; Cheung JW
Heart Rhythm; 2017 Dec; 14(12):1826-1832. PubMed ID: 28917564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
